Volume : 11, Issue : 09, September – 2024
Title:
A REVIEW ON ANALYTICAL METHODS FOR GLIBENCLAMIDE BY HPLC
Authors :
Banothu Bhadru*, Tadikonda Rama Rao, Sappidi Harshitha
Abstract :
Glibenclamide, or glyburide, is a second-generation sulfonylurea that effectively lowers blood sugar in type-2 diabetes patients who do not require insulin. Symptoms of low blood sugar may include excessive thirst, fatigue, dizziness, increased hunger, and blurred vision. It should be used alongside a proper diet and exercise and can be combined with other diabetes treatments, but is not suitable for type-1 diabetes. Common side effects include nausea, heartburn, weight gain, and bloating, with a notable risk of hypoglycemia and angioedema. Its use is generally discouraged during pregnancy but may be acceptable while breastfeeding. Glibenclamide stimulates insulin secretion from the pancreas and is contraindicated in patients with sulfonamide allergies, type-1 diabetes, ketoacidosis, or severe renal or hepatic impairment. This article also discusses validated analytical techniques, particularly High Performance Liquid Chromatography (HPLC), for quantifying Glibenclamide in pharmaceutical formulations.
Key words: Glibenclamide, HPLC, Accuracy, Precision, ICH, Validation
Cite This Article:
Please cite this article in press Banothu Bhadru et al., Review On Analytical Methods For Glibenclamide By HPLC, Indo Am. J. P. Sci, 2024; 11 (09).
Number of Downloads : 10
References:
1. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care. 2008; 31(2):161-164.
2. Akash M, Shen Q, Rehman K, Chen S. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci. 2012; 101(5):1647–1658.
3. Akash M, Rehman K, Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2013; 114(3):525–531.
4. Fagninou, Adnette & Tougan, Ulbad P. & Nekoua, Magloire & Ruffine, Fachina & Akadiri, Yessoufou. Diabetesmellitus: Classification, Epidemiology, Physiopathology, Immunology, Risk factors, Prevention and Nutrition. International Journal of Advanced Research. 2019;7(7):855-863
5. Jaber LA, Antal EJ, Welshman IR. Pharmacokinetics and pharmacodynamics of glyburide in young and elderly patients with non-insulin dependent diabetes mellitus. Ann Pharmacother. 1996; 30(5):472–475.
6. Ashwini M, Sogali BS, Bhattacharyya S. HPLC Method Development and Validation for determination of Glibenclamide in Pharmaceutical Dosage Forms. ‘Int. ‘Res.’J.’Pharm. 2019; 10 (4):117-120.
7. Oluwagbemisola J. Saheed Oluwasina Oseni. Physicochemical Equivalence and Validation of an HPLC Analytical Method for the Quantification of Glibenclamide and Its Sulfonamide Impurity in Prescribed Glibenclamide Tablets in Nigeria. Journal of Advances in Medicine and Medical Research, 2019; 29(1):1-17.
8. Febrina A, Saputri A. Development and validation of simple simultaneous analysis for amlodipine and Glibenclamide by non derivatization high-performance liquid chromatography-fluorescence. Journal of Advanced Pharmaceutical Technology & Research. 2018; 9(4):124–129.
9. Sheikh Hasibul Islam M, Alauddin F, Rafi Anwar. Development and validation of stability-Indicating RP-HPLC method for simultaneous estimation of Rosuvastatin and Glibenclamide. World Journal of Pharmacy and Pharmaceutical Sciences. 2018; 7(5):22–37.
10. Mallikarjun Bere, Pasham Venkanna. Method Development and Validation for Estimation of Glyburide (Glibenclamide) In Pharmaceutical Formulations and Rat Plasma by RP-HPLC. IJIRT.2021; 8(3); 833-844.
11. M. Jayanthi, S.V.Thirunavukkarasu, S. Raja. Development and Validation of RP-HPLC Method for Determination of Glibenclamide in Pharmaceutical Dosage Forms. International Journal of ChemTech Research .2012;4 (2), 593-601
12. B.Venkata Siva Rao & K. Anil Kumar. Analytical method Development and Validation for the assay of Metformin and Glibenclamide in bulk form by using RP-HPLC method. Int J Trends in Pharm & Life Sci. 2015; 1(5); 676-682.
13. Saputri A, Alawiyah A, Wira Kusuma AS. Development and validation of simple simultaneous analysis for amlodipine and glibenclamide by non-derivatization high-performance liquid chromatography-fluorescence. Journal of Advanced Pharmaceutical Technology & Research.2018; 9(4): 124–129.
14. Pranita J, Agrawal R, Chambhare N, Sahare AY. Development and Validation of Stability -Indicating RP-HPLC Method for Estimation of Glibenclamide in Bulk and Pharmaceutical Formulation. International Journal of Drug Delivery Technology. 2023; 13(3):875-883.
15. RK Godge, GS Shinde. RP-HPLC Method for estimation of Alogliptin and Glibenclamide in Synthetic mixture. Research Journal of Pharmacy and Technology. 2020; 13(2):555–559.
16. Mahmoud M, Sobhy M. Rapid RP-HPLC method for simultaneous estimation of some antidiabetics; Metformin, Gliclazide and Glimepiride in Tablets. Egyptian journal of chemistry. 2019; 62(3):429–440.
17. Basma M. Selima, Mahmoud M. Elkhoudaryb, Randa A. Development and Optimization of a Green Stability Indicating HPLC Method for the Determination Metformin HCL and Glibenclamide in their Dosage Form. Rec. Pharm. Biomed. Sci.2022; 6 (1), 84-100
18. Nazrul Haqa,b, Fars Kaed Alanazia,c, Ibrahim Abdullah Alsarra. Rapid Analysis of Glibenclamide Using an Environmentally Benign Stability-Indicating RP-HPLC Method.IJPR 2014; 13 (3): 863-872
19. Swati D Bhende, MB. Varanasi, konde abbulu. A sensitive HPTLC method for the estimation of Glibenclamide, rosiglitazone maleate and Metformin hydrochloride from a multi-componentdosageform.Journalofchromatographicscience.2020; 58(5):418-426.